中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
6期
13-14
,共2页
邓博%龚建安%刘永存%曾睿芳
鄧博%龔建安%劉永存%曾睿芳
산박%공건안%류영존%증예방
超声引导下定位导丝%触诊阴性%乳腺病灶切除
超聲引導下定位導絲%觸診陰性%乳腺病竈切除
초성인도하정위도사%촉진음성%유선병조절제
Wire localization guided by ultrasound%Nonpalpable negative breast lesion%Breast lesion resection
目的:探究运用超声引导下定位导丝辅助在临床触诊阴性的乳腺病灶切除中的临床应用价值和意义。方法:选取近3年在笔者所在医院接受治疗的180例触诊阴性的乳腺病灶患者,将其平均分为对照组和试验组两组,试验组运用超声引导下定位导丝辅助协助切除病灶,诊治疾病。对照组采用传统药物治疗。观察并比较两组患者的临床效果。结果:试验组与对照组经治疗后,试验组的总有效率(98.89%)明显高于对照组(72.22%),差异有统计学有意义(P<0.05)。结论:超声引导下定位导丝辅助诊断并治疗临床触诊阴性的乳腺病灶具有较好的临床效果,值得广泛应用和推广。
目的:探究運用超聲引導下定位導絲輔助在臨床觸診陰性的乳腺病竈切除中的臨床應用價值和意義。方法:選取近3年在筆者所在醫院接受治療的180例觸診陰性的乳腺病竈患者,將其平均分為對照組和試驗組兩組,試驗組運用超聲引導下定位導絲輔助協助切除病竈,診治疾病。對照組採用傳統藥物治療。觀察併比較兩組患者的臨床效果。結果:試驗組與對照組經治療後,試驗組的總有效率(98.89%)明顯高于對照組(72.22%),差異有統計學有意義(P<0.05)。結論:超聲引導下定位導絲輔助診斷併治療臨床觸診陰性的乳腺病竈具有較好的臨床效果,值得廣汎應用和推廣。
목적:탐구운용초성인도하정위도사보조재림상촉진음성적유선병조절제중적림상응용개치화의의。방법:선취근3년재필자소재의원접수치료적180례촉진음성적유선병조환자,장기평균분위대조조화시험조량조,시험조운용초성인도하정위도사보조협조절제병조,진치질병。대조조채용전통약물치료。관찰병비교량조환자적림상효과。결과:시험조여대조조경치료후,시험조적총유효솔(98.89%)명현고우대조조(72.22%),차이유통계학유의의(P<0.05)。결론:초성인도하정위도사보조진단병치료림상촉진음성적유선병조구유교호적림상효과,치득엄범응용화추엄。
Objective:To explore the application value and significance of wire localization guided by ultrasound assisted resection in nonpalpable breast lesions and clinical application.Method:Selected 180 cases nonpalpable breast lesions in recent three years in our hospital and they were average divided into control group and experimental group,experimental group used wire localization guided by ultrasound assisted resection and diagnosed the disease.The control group used the traditional drug.To observe and compare the clinical effects of two groups of patients.Result:The experimental group and control group after treatment,the total effective in experimental group(98.89%) was significantly higher than that in control group(72.22%),there was statistically significant(P<0.05). Conclusion:Wire localization guided by ultrasound in diagnosis and treatment of nonpalpable breast lesions has good clinical effect,and it is worthy of wide application and promotion.